Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ankur Sethi

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|March 6, 2018
A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main DiseaseVamsi Kodumuri, Senthil Balasubramanian, Aviral Vij, et al.
JACC. Cardiovascular Interventions|February 11, 2022
Safety and Efficacy of Single-Access Impella for High-Risk Percutaneous Intervention (SHiP)Abdul Hakeem, Delphine Tang, Kush Patel, et al.
The Canadian Journal of Cardiology|August 30, 2011
Tirofiban use with clopidogrel and aspirin decreases adverse cardiovascular events after percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trialsAnkur Sethi, Amol Bahekar, Hardik Doshi, et al.
Experimental and Clinical Cardiology|April 18, 2013
Drug-eluting stents versus bare metal stents in ST elevation myocardial infarction at a follow-up of three years or longer: A meta-analysis of randomized trialsAnkur Sethi, Amol Bahekar, Rohit Bhuriya, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 11, 2012
Glycoprotein IIb/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high-risk patients with ST elevation myocardial infarction--a meta-regression of randomized controlled trialsAnkur Sethi, Anurag Bajaj, Amol Bahekar, et al.
Archives of Cardiovascular Diseases|November 27, 2012
Zotarolimus-eluting stent versus sirolimus-eluting and paclitaxel-eluting stents for percutaneous coronary intervention: a meta-analysis of randomized trialsAnkur Sethi, Amol Bahekar, Rohit Bhuriya, et al.
Coronary Artery Disease|June 11, 2024
Trends in the incidence, mortality and clinical outcomes in patients with ventricular septal rupture following an ST-elevation myocardial infarctionEmily Hiltner, Marc Sandhaus, Ashish Awasthi, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 3, 2011
Prevention of recurrent atrial fibrillation with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a systematic review and meta-analysis of randomized trialsRohit Bhuriya, Mukesh Singh, Ankur Sethi, et al.
JACC. Advances|August 29, 2025
Outcomes of Telemedicine TAVR Preoperative EvaluationsJohn M Tobia, Sara Heinein, Fady Soliman, et al.
Cardiology|September 14, 2022
Sex Disparities in the Treatment of Aortic Stenosis and Related Outcomes: An Analysis of the National Inpatient SampleIkenna Erinne, Emily Hiltner, Varun Bhasin, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|March 6, 2018
A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main DiseaseVamsi Kodumuri, Senthil Balasubramanian, Aviral Vij, et al.
JACC. Cardiovascular Interventions|February 11, 2022
Safety and Efficacy of Single-Access Impella for High-Risk Percutaneous Intervention (SHiP)Abdul Hakeem, Delphine Tang, Kush Patel, et al.
The Canadian Journal of Cardiology|August 30, 2011
Tirofiban use with clopidogrel and aspirin decreases adverse cardiovascular events after percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trialsAnkur Sethi, Amol Bahekar, Hardik Doshi, et al.
Experimental and Clinical Cardiology|April 18, 2013
Drug-eluting stents versus bare metal stents in ST elevation myocardial infarction at a follow-up of three years or longer: A meta-analysis of randomized trialsAnkur Sethi, Amol Bahekar, Rohit Bhuriya, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 11, 2012
Glycoprotein IIb/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high-risk patients with ST elevation myocardial infarction--a meta-regression of randomized controlled trialsAnkur Sethi, Anurag Bajaj, Amol Bahekar, et al.
Archives of Cardiovascular Diseases|November 27, 2012
Zotarolimus-eluting stent versus sirolimus-eluting and paclitaxel-eluting stents for percutaneous coronary intervention: a meta-analysis of randomized trialsAnkur Sethi, Amol Bahekar, Rohit Bhuriya, et al.
Coronary Artery Disease|June 11, 2024
Trends in the incidence, mortality and clinical outcomes in patients with ventricular septal rupture following an ST-elevation myocardial infarctionEmily Hiltner, Marc Sandhaus, Ashish Awasthi, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 3, 2011
Prevention of recurrent atrial fibrillation with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a systematic review and meta-analysis of randomized trialsRohit Bhuriya, Mukesh Singh, Ankur Sethi, et al.
JACC. Advances|August 29, 2025
Outcomes of Telemedicine TAVR Preoperative EvaluationsJohn M Tobia, Sara Heinein, Fady Soliman, et al.
Cardiology|September 14, 2022
Sex Disparities in the Treatment of Aortic Stenosis and Related Outcomes: An Analysis of the National Inpatient SampleIkenna Erinne, Emily Hiltner, Varun Bhasin, et al.
Pageof 6